Voyager Therapeutics | 8-K: Current report
Voyager Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Voyager Therapeutics | 8-K: Voyager Therapeutics Reports Second Quarter 2024 Financial and Operating Results
Voyager Therapeutics | 8-K: Current report
Voyager Therapeutics | 8-K: Current report
Voyager Therapeutics | 8-K: Current report
Voyager Therapeutics | 8-K: Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results
Voyager Therapeutics | DEFA14A: Others
Voyager Therapeutics | DEF 14A: Definitive information statements
Voyager Therapeutics | 8-K: Current report
Voyager Therapeutics | 8-K: Current report
Voyager Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Voyager Therapeutics | 8-K: Voyager Therapeutics Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
Voyager Therapeutics | 8-K: Current report
Voyager Therapeutics | 8-K: Current report
Voyager Therapeutics | 8-K: Current report
Voyager Therapeutics | 8-K: Voyager Therapeutics Reports Third Quarter 2023 Financial and Operating Results
Voyager Therapeutics | 8-K: Current report
Voyager Therapeutics | 8-K: Voyager Therapeutics Reports Second Quarter 2023 Financial and Operating Results
Voyager Therapeutics | 8-K: Current report
No Data